In thyroid cancer, integrating ultrasound imaging with the analysis of Gal-3, c-MET, HBME-1, and CK19 expressions has proven helpful in distinguishing between malignant and benign thyroid nodules. The gene discussed is KRT19; the disease is thyroid gland carcinoma.